Member Info for red_rag_to_bull

Great to see a good bit of blue on the board today. I wonder if the Vistagen collab work will emerge fairly quickly and could catch out the market. I agree with those who would like a bit more clarity on the 'immediate revenue' statement. Anyway, enjoy the sunshine today everyone.

Personally, i agree with the poster that said that Vectura are beginning to look like they may take control of this entity. I'm not sure how this plays on the NXP002 deal, but my own feeling is that this is likely to now take the remainder of the year.
Having held and built a stake here for 24 months, the last 9 months have made the company look a bit of a basket case if I were an impartial observer. From what was defined as a pipeline now looks a little 'back of a fag packet'. Some sort of clear reset and direction of travel is needed.
Still holding and optimistic.

Maybe that person from a few days back who said he was going to pick up another million was actually true to his word...

Welcome aboard! Nice to see some positivity at the end of the week.
As a holder myself with a patiently accrued stack of shares myself, I hope (and believe) that you are correct. The 'fed-up' number here has been teetering over 1 this week. Maybe next week we can get it on a downward path (and the share price on an upward march). ATB

Totally agree on your summation. The RNS seemed to point towards an acceptance that it was time to move on and see if there are other takers for NXP001. I recognise that they will state they will continue to seek payments due, but that I took as simply legalese and implied by earlier RNS when previous legal guidance had been sought.
I had previously stated frustration with the lack of updates, but was reassured by much of what was said. The only part that read like it was a little rushed and not fully considered being that of the Ebers milestones - previously alluded to yesterday.
Holding and added yesterday. By December, i am hoping for a very Merry Christmas.

Right - I could have woken up in the wrong side today or perhaps I’m justified in expressing this, I really don’t know......but it seems like the management team have entered into ‘ Bermuda Triangle’ territory here with the lack of anything at all being said. I was prepared to wait things out for a while after Q1, but we are getting on closer to the end of Q2 now. I think an operational update is needed to be honest as the lack of understanding around things is just leading to frustration and speculation. I believe that this would help settle things into an upward trajectory (price includes) on what is a fairly stagnant situation.Not a happy chappy today... :(

Ox - i use HL for my own. Don't believe there are any caps other than the annual allowance (if that's what you mean).

Hey Clablard - totally agree. We should find out about the time Santa is socially distancing down the chimney pipe :)

I've put a few more into the ISA this morning, despite saying i was now done until news.
Lack of updates is frustrating me, but I'm inverting it into an expectation that there must be some payload being generated for future communications.
It's become pretty obvious to me that the only headwinds on this moving up is DT's drip-selling blocks into the market. Without that, I genuinely think this would be a couple of pence higher right now. ATB folks!

The data is knackered. I'm seeing 2 RNS and trades only to 13th February...I'm going to can my subs to this soon. Happens all too frequently.

Moves very fast on sustained buys. Nice to see some blue on the ticker!

Nice looking trades popping up on my L2 atm...

Morning all.
I was awake in the wee small hours last night and so decided to just go down a bit of an online rabbit-hole. Whilst doing a bit of searching on cocrystal, I found a couple of things that seemed of general interest. Maybe it's all known to the folks on here who do their own research.

1. Chris Blackwell (ex-Vectura): Vectura are worth taking a look at. They are very involved in inhaled treatment development and got me thinking if there may be a natural tie-in with NXP002. I had a look through the site and this was an interesting read: https://www.vectura.com/product-development/
2. Had a look at CoCrystal Pharma and they are now involved in a licensing agreement with Kansas State University Research Foundation. Cocrystal is investigating lead candidates from a program of antiviral compounds, applying its structure-based platform technology, for treatment of COVID-19. Seems like this is something that NFX could easily be working on under the radar during this silence. There is a really useful list of known treatment developments related to COVID-19 here for those interested in taking a look. A couple of mentions of repurposing and inhaled delivery of treatments: https://www.bioworld.com/COVID19products

A bit off-topic, but thought i'd post anyway....anything to alleviate the boredom! :)

Lots of nonsense on the board atm. I've topped up earlier again today before the end of the tax year. I see no issues with the current situation and happy to wait this out.
We're not in normal times and I don't really think expectations (and semantics or interpretation of language) are a useful guide to anything at present. The only constant i'm seeing is "Stay Home, Protect the NHS, Save Lives"....
All the best to you all!

The last one back in Feb came in at 5:05pm....i was thinking that earlier.

Scooby - i just added around 25k more @ 4.80 in the last ten mins. Took a long time to get a quote but can see a rise coming from the look of the book.

Not seen anything further re. bailout, but say this earlier today: https://gulfnews.com/business/uae-hospital-operator-nmc-to-initiate-legal-action-against-ex-management-1.1585025108906

I'm in agreement with this sentiment. I would much prefer silence (and hopefully talks/negotiations) than the loose lips that spiked this up on the Kissei speculation.

Last top-up for me. Slowly been chipping away over 14 months to build my position. Currently averaging 6.7, so that NXP002 news next week would be welcome, but only if it's the right deal. It's so important to get it right so would happily wait beyond Q1 if it's not aligned to expectations and long-term value.

Some very interesting notes from the investment bank Jeffries have been reported by The Guardian, particularly the numbers of COVID-19 tested in select countries. Note how few have actually been tested in the US. Seems a little bit odd to me that so few have been tested...
https://www.theguardian.com/business/live/2020/feb/25/stock-market-sell-off-coronavirus-companies-croda-dow-ftse-business-live?page=with:block-5e554a438f08e13324749f34#block-5e554a438f08e13324749f34